According to our (Global Info Research) latest study, the global Streptavidin SPR Chip market size was valued at US$ 54.53 million in 2025 and is forecast to a readjusted size of US$ 86.62 million by 2032 with a CAGR of 7.0% during review period.
Streptavidin SPR chips are SPR consumables in which streptavidin is pre-immobilized or forms a streptavidin capture layer on gold films, prisms, or sensor substrates via accompanying reagents. They are used for high-affinity capture of biotinylated proteins, peptides, nucleic acids, glycans, and other ligands, enabling affinity, kinetics, and screening analyses. The product’s gross margin is approximately 62%.
Demand for streptavidin SPR chips mainly comes from biopharmaceutical R&D, CRO testing, antibody/ADC characterization, and early-stage small-molecule screening. The streptavidin–biotin system offers high affinity and good oriented immobilization, suitable for ligands that are easily inactivated after covalent coupling, require directional capture, or need stable, long-term repeated injections. Therefore, stable demand exists across Biacore, Octet SPR, OpenSPR, MP-SPR, and SPRi platforms.
On the supply side, the market shows a mix of platform-bound and compatible chips. Instrument vendors such as Cytiva and Sartorius leverage installed base and validation systems to maintain high pricing, while specialized surface suppliers like XanTec, BioNavis, and Reichert meet replacement demand through varied matrices, capacities, and compatible formats. Domestic SPR platforms are beginning to provide SA chips, but overall remain in the stage of import substitution and platform adaptation.
Future growth is primarily driven by drug discovery needs for high-throughput, low-sample-volume, and renewable capture surfaces. SA chips are not the most general-purpose chips—their market size is smaller than CM5/CM-dextran chips—but they have high unit prices, clear repurchase patterns, and are indispensable for biotinylated targets, antibody screening, nucleic acid aptamers, and membrane protein analyses. They are expected to maintain moderate growth above the overall life science consumables market.
This report is a detailed and comprehensive analysis for global Streptavidin SPR Chip market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Streptavidin SPR Chip market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Streptavidin SPR Chip market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Streptavidin SPR Chip market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Streptavidin SPR Chip market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Streptavidin SPR Chip
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Streptavidin SPR Chip market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Sartorius, Nicoya, XanTec, BioNavis, Biosensing Instrument, Reichert, Carterra, Malvern Panalytical, Polariton Life, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Streptavidin SPR Chip market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pre-Immobilized Streptavidin
On-Chip Streptavidin Kit
Regenerable Streptavidin
Custom Streptavidin Surface
Other Capture Surface
Market segment by Platform Format
Biacore Format
Octet SPR Format
OpenSPR Format
MP-SPR Slide
SPRi Array Format
Other Format
Market segment by Capture Capacity
Low Capacity
Medium Capacity
High Capacity
Very High Capacity
Custom Capacity
Market segment by Application
Protein Kinetics
Small-Molecule Screening
Antibody Characterization
Nucleic Acid Binding
Peptide Binding
Biomarker Assay Development
Biosensor Surface Development
Major players covered
Cytiva
Sartorius
Nicoya
XanTec
BioNavis
Biosensing Instrument
Reichert
Carterra
Malvern Panalytical
Polariton Life
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Streptavidin SPR Chip product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Streptavidin SPR Chip, with price, sales quantity, revenue, and global market share of Streptavidin SPR Chip from 2021 to 2026.
Chapter 3, the Streptavidin SPR Chip competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Streptavidin SPR Chip breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Streptavidin SPR Chip market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Streptavidin SPR Chip.
Chapter 14 and 15, to describe Streptavidin SPR Chip sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Streptavidin SPR Chip. Industry analysis & Market Report on Streptavidin SPR Chip is a syndicated market report, published as Global Streptavidin SPR Chip Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Streptavidin SPR Chip market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.